What's the news?
Pharmeasy is in talks with SoftBank for a fund infusion of $150 Mn – $200 Mn at a valuation of $5.6 Bn, according to a report by financial daily ET. The healthtech unicorn is also targeting an IPO in the next 12 to 18 months. The company completed a series F round that raised $500 Mn and valued the firm at nearly $4 Bn. its co-founder and chief executive officer Siddharth Shah said on Bloomberg TV.
More to know
PharmEasy has so far delivered more than 15 Mn orders from medicine to diagnostic kits to health care products, serving over 5 Mn families, according to its website. The company last month bought a majority stake in Thyrocare Technologies Ltd. for $610 Mn.